JUVENILE PARKINSONS-DISEASE AND ITS RESPONSE TO L-DOPA THERAPY

被引:2
|
作者
ASKENASY, JJM [1 ]
MENDELSON, L [1 ]
KEREN, O [1 ]
BRAUN, Z [1 ]
机构
[1] TEL AVIV UNIV,LOEWENSTEIN REHABIL HOSP,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL
关键词
Childhood appearance; circadian fluctuations; dystonic foot onset; early "on-off phenomena; familial incidence; low dose levodopa responsiveness;
D O I
10.1007/BF02251243
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Four youngsters, between the ages of 13-27 years, presented dystonic foot. Two to three years following the appearance of the dystonic foot, cogwheel rigidity and tremor appeared on the dystonic foot side. Treatment with low doses of levodopa/carbidopa consistently reversed the symptoms. "On-off" phenomena appeared in the first years of treatment and persisted for the entire period of 5 to 15 years of illness. No parkinsonian signs were present when the dystonic foot appeared. Based on our observations and on a review of the literature, we conclude that responsiveness to low doses of L-dopa is the major maker of juvenile Parkinson's disease. © 1990 Springer-Verlag.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [1] INITIAL RESPONSE TO L-DOPA IN PARKINSONS-DISEASE
    GANCHER, ST
    NUTT, JG
    ANNALS OF NEUROLOGY, 1987, 22 (01) : 173 - 173
  • [2] NEUROCHEMISTRY OF PARKINSONS-DISEASE - EFFECT OF L-DOPA THERAPY
    LLOYD, KG
    DAVIDSON, L
    HORNYKIEWICZ, O
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1975, 195 (03): : 453 - 464
  • [3] L-DOPA TREATMENT AND PARKINSONS-DISEASE
    LEES, AJ
    QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (230): : 535 - 547
  • [4] L-DOPA ACTION IN PARKINSONS-DISEASE
    MARSDEN, CD
    JENNER, P
    TRENDS IN NEUROSCIENCES, 1981, 4 (06) : 148 - 150
  • [5] L-DOPA AND OCULOMOTORICITY IN PARKINSONS-DISEASE
    RASCOL, O
    CLANET, M
    FRAYSSE, B
    SOULIER, MJ
    SIMONETTA, M
    DESCOUENS, D
    MONTASTRUC, JL
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1988, 96 (03): : A127 - A127
  • [6] THE BEREITSCHAFTSPOTENTIAL, L-DOPA AND PARKINSONS-DISEASE
    DICK, JPR
    CANTELLO, R
    BURUMA, O
    GIOUX, M
    BENECKE, R
    DAY, BL
    ROTHWELL, JC
    THOMPSON, PD
    MARSDEN, CD
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1987, 66 (03): : 263 - 274
  • [7] THE L-DOPA TEST IN PARKINSONS-DISEASE
    ESTEGUY, M
    BONNET, AM
    KEFALOS, J
    LHERMITTE, F
    AGID, Y
    REVUE NEUROLOGIQUE, 1985, 141 (05) : 413 - 415
  • [8] L-DOPA IN PARKINSONS-DISEASE - REPLY
    BRANNAN, TS
    MARTINEZ, J
    YAHR, MD
    NEUROLOGY, 1991, 41 (10) : 1709 - 1709
  • [9] SLEEP IN PATIENTS WITH PARKINSONS-DISEASE AND ITS INFLUENCE BY L-DOPA
    SCHNEIDER, E
    MAXION, H
    ZIEGLER, B
    JACOBI, P
    JOURNAL OF NEUROLOGY, 1974, 207 (02) : 95 - 108
  • [10] DEMENTIA AND TREATMENT WITH L-DOPA IN PARKINSONS-DISEASE
    HIETANEN, M
    TERAVAINEN, H
    MOVEMENT DISORDERS, 1988, 3 (03) : 263 - 270